UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ARFGEF1-CPA6 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ARFGEF1-CPA6 | FusionPDB ID: 5850 | FusionGDB2.0 ID: 5850 | Hgene | Tgene | Gene symbol | ARFGEF1 | CPA6 | Gene ID | 10565 | 57094 |
Gene name | ADP ribosylation factor guanine nucleotide exchange factor 1 | carboxypeptidase A6 | |
Synonyms | ARFGEP1|BIG1|P200 | CPAH|ETL5|FEB11 | |
Cytomap | 8q13.2 | 8q13.2 | |
Type of gene | protein-coding | protein-coding | |
Description | brefeldin A-inhibited guanine nucleotide-exchange protein 1ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)p200 ARF guanine nucleotide exchange factor | carboxypeptidase A6carboxypeptidase B | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q9Y6D6 | Q8N4T0 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000262215, ENST00000520381, ENST00000517955, ENST00000518230, | ENST00000518549, ENST00000297769, ENST00000297770, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 14 X 14 X 6=1176 | 7 X 9 X 5=315 |
# samples | 17 | 9 | |
** MAII score | log2(17/1176*10)=-2.79028140869866 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/315*10)=-1.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ARFGEF1 [Title/Abstract] AND CPA6 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ARFGEF1(68255399)-CPA6(68334926), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | ARFGEF1-CPA6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ARFGEF1-CPA6 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ARFGEF1-CPA6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ARFGEF1-CPA6 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. ARFGEF1-CPA6 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. ARFGEF1-CPA6 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ARFGEF1 | GO:0034260 | negative regulation of GTPase activity | 15644318 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-A8-A09N-01A | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - |
ChimerDB4 | BRCA | TCGA-E2-A14Y-01A | ARFGEF1 | chr8 | 68255399 | - | CPA6 | chr8 | 68334926 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000520381 | ARFGEF1 | chr8 | 68150970 | - | ENST00000297769 | CPA6 | chr8 | 68397024 | - | 2292 | 1568 | 32 | 1957 | 641 |
ENST00000520381 | ARFGEF1 | chr8 | 68150970 | - | ENST00000297770 | CPA6 | chr8 | 68397024 | - | 2577 | 1568 | 32 | 2245 | 737 |
ENST00000520381 | ARFGEF1 | chr8 | 68150970 | - | ENST00000518549 | CPA6 | chr8 | 68397024 | - | 2256 | 1568 | 32 | 1879 | 615 |
ENST00000262215 | ARFGEF1 | chr8 | 68150970 | - | ENST00000297769 | CPA6 | chr8 | 68397024 | - | 4252 | 3528 | 390 | 3917 | 1175 |
ENST00000262215 | ARFGEF1 | chr8 | 68150970 | - | ENST00000297770 | CPA6 | chr8 | 68397024 | - | 4537 | 3528 | 390 | 4205 | 1271 |
ENST00000262215 | ARFGEF1 | chr8 | 68150970 | - | ENST00000518549 | CPA6 | chr8 | 68397024 | - | 4216 | 3528 | 390 | 3839 | 1149 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000520381 | ENST00000297769 | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - | 0.000641109 | 0.99935895 |
ENST00000520381 | ENST00000297770 | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - | 0.000638941 | 0.9993611 |
ENST00000520381 | ENST00000518549 | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - | 0.000691828 | 0.9993082 |
ENST00000262215 | ENST00000297769 | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - | 0.000663315 | 0.99933666 |
ENST00000262215 | ENST00000297770 | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - | 0.000656099 | 0.99934393 |
ENST00000262215 | ENST00000518549 | ARFGEF1 | chr8 | 68150970 | - | CPA6 | chr8 | 68397024 | - | 0.000514581 | 0.9994854 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >5850_5850_1_ARFGEF1-CPA6_ARFGEF1_chr8_68150970_ENST00000262215_CPA6_chr8_68397024_ENST00000297769_length(amino acids)=1175AA_BP=1046 MYEGKKTKNMFLTRALEKILADKEVKKAHHSQLRKACEVALEEIKAETEKQSPPHGEAKAGSSTLPPVKSKTNFIEADKYFLPFELACQS KCPRIVSTSLDCLQKLIAYGHLTGNAPDSTTPGKKLIDRIIETICGCFQGPQTDEGVQLQIIKALLTAVTSQHIEIHEGTVLQAVRTCYN IYLASKNLINQTTAKATLTQMLNVIFARMENQALQEAKQMEKERHRQHHHLLQSPVSHHEPESPQLRYLPPQTVDHISQEHEGDLDLHTN DVDKSLQDDTEPENGSDISSAENEQTEADQATAAETLSKNEVLYDGENHDCEEKPQDIVQNIVEEMVNIVVGDMGEGTTINASADGNIGT IEDGSDSENIQANGIPGTPISVAYTPSLPDDRLSVSSNDTQESGNSSGPSPGAKFSHILQKDAFLVFRSLCKLSMKPLSDGPPDPKSHEL RSKILSLQLLLSILQNAGPIFRTNEMFINAIKQYLCVALSKNGVSSVPEVFELSLSIFLTLLSNFKTHLKMQIEVFFKEIFLYILETSTS SFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMVEWSKDQ YVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPKRGIQYL QEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKFAARYLE CNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPTKSSKQN VASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAIRIACIF SIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEALLTYKSDPAMRKMLNHLYFYIMPVFNVDGYHFS WTNDRFWRKTRSRNSRFRCRGVDANRNWKVKWCDVSSGSSMDWAYKNGIPYAFAFELRDTGYFGFLLPEMLIKPTCTETMLAVKNITMHL -------------------------------------------------------------- >5850_5850_2_ARFGEF1-CPA6_ARFGEF1_chr8_68150970_ENST00000262215_CPA6_chr8_68397024_ENST00000297770_length(amino acids)=1271AA_BP=1046 MYEGKKTKNMFLTRALEKILADKEVKKAHHSQLRKACEVALEEIKAETEKQSPPHGEAKAGSSTLPPVKSKTNFIEADKYFLPFELACQS KCPRIVSTSLDCLQKLIAYGHLTGNAPDSTTPGKKLIDRIIETICGCFQGPQTDEGVQLQIIKALLTAVTSQHIEIHEGTVLQAVRTCYN IYLASKNLINQTTAKATLTQMLNVIFARMENQALQEAKQMEKERHRQHHHLLQSPVSHHEPESPQLRYLPPQTVDHISQEHEGDLDLHTN DVDKSLQDDTEPENGSDISSAENEQTEADQATAAETLSKNEVLYDGENHDCEEKPQDIVQNIVEEMVNIVVGDMGEGTTINASADGNIGT IEDGSDSENIQANGIPGTPISVAYTPSLPDDRLSVSSNDTQESGNSSGPSPGAKFSHILQKDAFLVFRSLCKLSMKPLSDGPPDPKSHEL RSKILSLQLLLSILQNAGPIFRTNEMFINAIKQYLCVALSKNGVSSVPEVFELSLSIFLTLLSNFKTHLKMQIEVFFKEIFLYILETSTS SFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMVEWSKDQ YVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPKRGIQYL QEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKFAARYLE CNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPTKSSKQN VASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAIRIACIF SIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEALLTYKSDPAMRKMLNHLYFYIMPVFNVDGYHFS WTNDRFWRKTRSRNSRFRCRGVDANRNWKVKWCDEGASMHPCDDTYCGPFPESEPEVKAVANFLRKHRKHIRAYLSFHAYAQMLLYPYSY KYATIPNFRCVESAAYKAVNALQSVYGVRYRYGPASTTLYVSSGSSMDWAYKNGIPYAFAFELRDTGYFGFLLPEMLIKPTCTETMLAVK -------------------------------------------------------------- >5850_5850_3_ARFGEF1-CPA6_ARFGEF1_chr8_68150970_ENST00000262215_CPA6_chr8_68397024_ENST00000518549_length(amino acids)=1149AA_BP=1046 MYEGKKTKNMFLTRALEKILADKEVKKAHHSQLRKACEVALEEIKAETEKQSPPHGEAKAGSSTLPPVKSKTNFIEADKYFLPFELACQS KCPRIVSTSLDCLQKLIAYGHLTGNAPDSTTPGKKLIDRIIETICGCFQGPQTDEGVQLQIIKALLTAVTSQHIEIHEGTVLQAVRTCYN IYLASKNLINQTTAKATLTQMLNVIFARMENQALQEAKQMEKERHRQHHHLLQSPVSHHEPESPQLRYLPPQTVDHISQEHEGDLDLHTN DVDKSLQDDTEPENGSDISSAENEQTEADQATAAETLSKNEVLYDGENHDCEEKPQDIVQNIVEEMVNIVVGDMGEGTTINASADGNIGT IEDGSDSENIQANGIPGTPISVAYTPSLPDDRLSVSSNDTQESGNSSGPSPGAKFSHILQKDAFLVFRSLCKLSMKPLSDGPPDPKSHEL RSKILSLQLLLSILQNAGPIFRTNEMFINAIKQYLCVALSKNGVSSVPEVFELSLSIFLTLLSNFKTHLKMQIEVFFKEIFLYILETSTS SFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMVEWSKDQ YVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPKRGIQYL QEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKFAARYLE CNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPTKSSKQN VASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAIRIACIF SIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEALLTYKSDPAMRKMLNHLYFYIMPVFNVDGYHFS -------------------------------------------------------------- >5850_5850_4_ARFGEF1-CPA6_ARFGEF1_chr8_68150970_ENST00000520381_CPA6_chr8_68397024_ENST00000297769_length(amino acids)=641AA_BP=512 METSTSSFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMV EWSKDQYVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPK RGIQYLQEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKF AARYLECNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPT KSSKQNVASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAI RIACIFSIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEALLTYKSDPAMRKMLNHLYFYIMPVFNV DGYHFSWTNDRFWRKTRSRNSRFRCRGVDANRNWKVKWCDVSSGSSMDWAYKNGIPYAFAFELRDTGYFGFLLPEMLIKPTCTETMLAVK -------------------------------------------------------------- >5850_5850_5_ARFGEF1-CPA6_ARFGEF1_chr8_68150970_ENST00000520381_CPA6_chr8_68397024_ENST00000297770_length(amino acids)=737AA_BP=512 METSTSSFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMV EWSKDQYVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPK RGIQYLQEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKF AARYLECNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPT KSSKQNVASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAI RIACIFSIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEALLTYKSDPAMRKMLNHLYFYIMPVFNV DGYHFSWTNDRFWRKTRSRNSRFRCRGVDANRNWKVKWCDEGASMHPCDDTYCGPFPESEPEVKAVANFLRKHRKHIRAYLSFHAYAQML LYPYSYKYATIPNFRCVESAAYKAVNALQSVYGVRYRYGPASTTLYVSSGSSMDWAYKNGIPYAFAFELRDTGYFGFLLPEMLIKPTCTE -------------------------------------------------------------- >5850_5850_6_ARFGEF1-CPA6_ARFGEF1_chr8_68150970_ENST00000520381_CPA6_chr8_68397024_ENST00000518549_length(amino acids)=615AA_BP=512 METSTSSFDHKWMVIQTLTRICADAQSVVDIYVNYDCDLNAANIFERLVNDLSKIAQGRGSQELGMSNVQELSLRKKGLECLVSILKCMV EWSKDQYVNPNSQTTLGQEKPSEQEMSEIKHPETINRYGSLNSLESTSSSGIGSYSTQMSGTDNPEQFEVLKQQKEIIEQGIDLFNKKPK RGIQYLQEQGMLGTTPEDIAQFLHQEERLDSTQVGEFLGDNDKFNKEVMYAYVDQHDFSGKDFVSALRMFLEGFRLPGEAQKIDRLMEKF AARYLECNQGQTLFASADTAYVLAYSIIMLTTDLHSPQVKNKMTKEQYIKMNRGINDSKDLPEEYLSAIYNEIAGKKISMKETKELTIPT KSSKQNVASEKQRRLLYNLEMEQMAKTAKALMEAVSHVQAPFTSATHLEHVRPMFKLAWTPFLAAFSVGLQDCDDTEVASLCLEGIRCAI RIACIFSIQLERDAYVQALARFTLLTVSSGITEMKQKNIDTIKTLITVAHTDGNYLGNSWHEALLTYKSDPAMRKMLNHLYFYIMPVFNV -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:68255399/chr8:68334926) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ARFGEF1 | CPA6 |
FUNCTION: Promotes guanine-nucleotide exchange on ARF1 and ARF3. Promotes the activation of ARF1/ARF3 through replacement of GDP with GTP. Involved in vesicular trafficking. Required for the maintenance of Golgi structure; the function may be independent of its GEF activity. Required for the maturaion of integrin beta-1 in the Golgi. Involved in the establishment and persistence of cell polarity during directed cell movement in wound healing. Proposed to act as A kinase-anchoring protein (AKAP) and may mediate crosstalk between Arf and PKA pathways. Inhibits GAP activity of MYO9B probably through competetive RhoA binding. The function in the nucleus remains to be determined. {ECO:0000269|PubMed:12571360, ECO:0000269|PubMed:15644318, ECO:0000269|PubMed:17227842, ECO:0000269|PubMed:20360857, ECO:0000269|PubMed:22084092}. | FUNCTION: May be involved in the proteolytic inactivation of enkephalins and neurotensin in some brain areas. May convert inactive angiotensin I into the biologically active angiotensin II (PubMed:18178555). Releases a C-terminal amino acid, with preference for large hydrophobic C-terminal amino acids and shows only very weak activity toward small amino acids and histidine (PubMed:20855895). {ECO:0000269|PubMed:18178555, ECO:0000269|PubMed:20855895}. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ARFGEF1 | chr8:68150970 | chr8:68397024 | ENST00000262215 | - | 21 | 39 | 709_840 | 1046.0 | 1850.0 | Domain | SEC7 |
Hgene | ARFGEF1 | chr8:68150970 | chr8:68397024 | ENST00000262215 | - | 21 | 39 | 711_715 | 1046.0 | 1850.0 | Motif | Note=Nuclear localization signal (NLS) |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000297769 | 5 | 9 | 196_199 | 64.0 | 194.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000297769 | 5 | 9 | 271_272 | 64.0 | 194.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000297769 | 5 | 9 | 325_326 | 64.0 | 194.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000297770 | 5 | 11 | 271_272 | 212.0 | 438.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000297770 | 5 | 11 | 325_326 | 212.0 | 438.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000518549 | 5 | 8 | 271_272 | 212.0 | 316.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000518549 | 5 | 8 | 325_326 | 212.0 | 316.0 | Region | Substrate binding |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000297770 | 5 | 11 | 196_199 | 212.0 | 438.0 | Region | Substrate binding | |
Tgene | CPA6 | chr8:68150970 | chr8:68397024 | ENST00000518549 | 5 | 8 | 196_199 | 212.0 | 316.0 | Region | Substrate binding |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ARFGEF1 | |
CPA6 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ARFGEF1-CPA6 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ARFGEF1-CPA6 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |